BRF2


Summary: This gene encodes one of the multiple subunits of the RNA polymerase III transcription factor complex required for transcription of genes with promoter elements upstream of the initiation site. The product of this gene, a TFIIB-like factor, is directly recruited to the TATA-box of polymerase III small nuclear RNA gene promoters through its interaction with the TATA-binding protein. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in BRF2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IDA GO:0001032 RNA polymerase III type 3 promoter DNA binding
MF IEA GO:0046872 metal ion binding
CC IMP GO:0000126 transcription factor TFIIIB complex
CC TAS GO:0005654 nucleoplasm
BP IMP GO:0006359 regulation of transcription by RNA polymerase III
BP IMP GO:0034599 cellular response to oxidative stress
Showing 1 to 6 of 7 rows

Gene expression in normal tissue: BRF2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined12Longevity regulating pathway1VEGF signaling pathway1Ferroptosis1

Pathways in BRF2


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-74158 RNA Polymerase III Transcription
reactome R-HSA-74158 RNA Polymerase III Transcription
reactome R-HSA-74160 Gene expression (Transcription)
reactome R-HSA-74160 Gene expression (Transcription)
reactome R-HSA-749476 RNA Polymerase III Abortive And Retractive Initiation
reactome R-HSA-76046 RNA Polymerase III Transcription Initiation
Showing 1 to 6 of 9 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD780 PP-30 3
iGMDRD887 Compound 23 citrate 3
iGMDRD882 CIL41 3
iGMDRD132 (-)-gallocatechin-3-O-gallate 3
Showing 1 to 4 of 15 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in BRF2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​